Evidence map›Paper›PMID 26083118›Full record

ArticleNutrients2015

γ-Oryzanol Enhances Adipocyte Differentiation and Glucose Uptake.

Chang Hwa Jung, Da-Hye Lee, Jiyun Ahn, Hyunjung Lee, Won Hee Choi, Young Jin Jang, Tae-Youl Ha

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Proteomic Analysis of the Effects of Shenzhu Tiaopi Granules on Model Rats with Type 2 Diabetes Mellitus.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025
    Article
  5. Nutrients · 2023
    Article
  6. Gamma-oryzanol dose optimization in maturation or culture media forIranian journal of veterinary research · 2023
    Article
  7. Inhibitory evaluation ofJournal of enzyme inhibition and medicinal chemistry · 2021
    Article
  8. New Insights for nicotinamide: Metabolic disease, autophagy, and mTOR.Frontiers in bioscience (Landmark edition) · 2020
    Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Antioxidant Activity of γ-Oryzanol: A Complex Network of Interactions.International journal of molecular sciences · 2016
    Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Chang Hwa JungDepartment of Food Biotechnology, Korea University of Science and Technology, 1201 Anyangpangyo-ro, Bundang-ku, Seongnam 463-746, Korea. chjung@kfri.re.kr.
Da-Hye LeeDepartment of Food Biotechnology, Korea University of Science and Technology, 1201 Anyangpangyo-ro, Bundang-ku, Seongnam 463-746, Korea. dlekgp26@nate.com.
Jiyun AhnDepartment of Food Biotechnology, Korea University of Science and Technology, 1201 Anyangpangyo-ro, Bundang-ku, Seongnam 463-746, Korea. jyan@kfri.re.kr.
Hyunjung LeeMetabolic Mechanism Research Group, Korea Food Research Institute, 1201 Anyangpangyo-ro, Bundang-ku, Seongnam 463-746, Korea. Lee.Hyun-jung@kfri.re.kr.
Won Hee ChoiDepartment of Food Biotechnology, Korea University of Science and Technology, 1201 Anyangpangyo-ro, Bundang-ku, Seongnam 463-746, Korea. kfri2@daum.net.
Young Jin JangMetabolic Mechanism Research Group, Korea Food Research Institute, 1201 Anyangpangyo-ro, Bundang-ku, Seongnam 463-746, Korea. jyj616@kfri.re.kr.
Tae-Youl HaDepartment of Food Biotechnology, Korea University of Science and Technology, 1201 Anyangpangyo-ro, Bundang-ku, Seongnam 463-746, Korea. tyhap@kfri.re.kr.
Korea Food Research Institute · KRKorea University of Science and Technology · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies show that brown rice improves glucose intolerance and potentially the risk of diabetes, although the underlying molecular mechanisms remain unclear. One of the phytochemicals found in high concentration in brown rice is γ-oryzanol (Orz), a group of ferulic acid esters of phytosterols and triterpene alcohols. Here, we found that Orz stimulated differentiation of 3T3-L1 preadipocytes and increased the protein expression of adipogenic marker genes such as peroxisome proliferator-activated receptor gamma (PPAR-γ) and CCAAT/enhanced binding protein alpha (C/EBPα). Moreover, Orz significantly increased the glucose uptake in insulin-resistant cells and translocation of glucose transporter type 4 (GLUT4) from the cytosol to the cell surface. To investigate the mechanism by which Orz stimulated cell differentiation, we examined its effects on cellular signaling of the mammalian target of rapamycin complex 1 (mTORC1), a central mediator of cellular growth and proliferation. The Orz treatment increased mTORC1 kinase activity based on phosphorylation of 70-kDa ribosomal S6 kinase 1 (S6K1). The effect of Orz on adipocyte differentiation was dependent on mTORC1 activity because rapamycin blocks cell differentiation in Orz-treated cells. Collectively, our results indicate that Orz stimulates adipocyte differentiation, enhances glucose uptake, and may be associated with cellular signaling mediated by PPAR-γ and mTORC1.

Indexed as

3T3-L1 CellsAdipocytesAnimalsCCAAT-Enhancer-Binding ProteinsCell DifferentiationCell SurvivalGene Expression RegulationGlucoseGlucose Transporter Type 4Insulin ResistanceMechanistic Target of Rapamycin Complex 1MiceMultiprotein ComplexesOryzaPhenylpropionatesPhosphorylationCCAAT-Enhancer-Binding ProteinsCEBPA protein, mousegamma-oryzanolGlucoseGlucose Transporter Type 4Mechanistic Target of Rapamycin Complex 1Multiprotein ComplexesPhenylpropionatesPhytochemicalsPPAR gammaRibosomal Protein S6 Kinases, 90-kDaRps6ka1 protein, mouseSlc2a4 protein, mouseTOR Serine-Threonine Kinases3T3-L1adipocyteglucose uptakemTORC1PPAR-γγ-oryzanol

Identifiers

PMID26083118
PMCPMC4488819
OpenAlexW2144593691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.